These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11561037)

  • 21. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
    Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
    Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models.
    Hübener J; Riess O
    Neurobiol Dis; 2010 Apr; 38(1):116-24. PubMed ID: 20079840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL.
    Chou AH; Yeh TH; Kuo YL; Kao YC; Jou MJ; Hsu CY; Tsai SR; Kakizuka A; Wang HL
    Neurobiol Dis; 2006 Feb; 21(2):333-45. PubMed ID: 16112867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions.
    Takahashi J; Fukuda T; Tanaka J; Minamitani M; Fujigasaki H; Uchihara T
    Acta Neuropathol; 2000 May; 99(5):589-94. PubMed ID: 10805106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.
    Chou AH; Lin AC; Hong KY; Hu SH; Chen YL; Chen JY; Wang HL
    Neurochem Int; 2011 Feb; 58(2):145-52. PubMed ID: 21092747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [INTRANUCLEAR UBIQUITIN-IMMUNOPOSITIVE STRUCTURES OF THE HUMAN SUBSTANTIA NIGRA NEURONS].
    Grigoriev IP; Korzhevskii DE; Sukhorukova EG; Gusel'nikova VV; Kirik OV
    Tsitologiia; 2015; 57(11):780-7. PubMed ID: 27012092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [DISTRIBUTION OF THE MARINESCO BODIES IN THE NEURONS OF HUMAN BRAIN SUBSTANTIA NIGRA].
    Grigoriyev IP; Gusel'nikova VV; Sukhorukova YG; Korzhevskiy DE
    Morfologiia; 2015; 148(5):28-31. PubMed ID: 26987214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
    Paulson HL; Das SS; Crino PB; Perez MK; Patel SC; Gotsdiner D; Fischbeck KH; Pittman RN
    Ann Neurol; 1997 Apr; 41(4):453-62. PubMed ID: 9124802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.
    Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S
    J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
    Matsumoto M
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
    [No Abstract]   [Full Text] [Related]  

  • 36. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology of CAG repeat diseases.
    Yamada M; Tsuji S; Takahashi H
    Neuropathology; 2000 Dec; 20(4):319-25. PubMed ID: 11211058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Stenoien DL; Mielke M; Mancini MA
    Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
    Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study.
    Ono S; Inoue K; Mannen T; Mitake S; Shirai T; Kanda F; Jinnai K; Takahashi K
    Acta Neuropathol; 1989; 77(4):350-6. PubMed ID: 2540609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.